Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00430001
Status:
UNKNOWN
Last Update Posted:
2008-05-09
First Post:
2007-01-30
Brief Title:
Vinorelbine Plus Trastuzumab vs Docetaxel Plus Trastuzumab as 1 Line Treatment for HER2 Positive Metastatic Breast Cancer
Sponsor:
Danish Breast Cancer Cooperative Group
Organization:
Danish Breast Cancer Cooperative Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-05
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2008-12
Completion Date Type:
ESTIMATED
First Submit Date:
2007-01-30
First Submit QC Date:
January 31 2007
Study First Post Date:
2007-02-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-05-06
Last Update Post Date:
2008-05-09
Last Update Post Date Type:
ESTIMATED